Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-02-25 16:17:28
Reporting Period:
Accepted Time:
2019-02-25 16:17:28
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1272353 David Lawrence 420 Saw Mill River Road
Ardsley NY 10502
Chief, Bus. Ops & Pao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-22 761 $13.18 5,092 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Reflects the number of shares of the issuer's Common Stock that were sold to cover tax liability in connection with settlement of restricted stock units that vested as reported on a prior Form 4.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $12.9666 to $13.18000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.